News & Perspective

Nov 28, 2017

Nov 28, 2017

News Scan for Nov 28, 2017

Scarlet fever resurgence
Plague outbreak contained
MERS cases
Yemen diphtheria supplies
Shoddy medical products
Malaria drug application

Nov 02, 2017

Nov 02, 2017

News Scan for Nov 02, 2017

Plague in Madagascar
New Saudi MERS case
UK flu vaccine protection
IDSA against CHAMPION Act

Jun 07, 2017

Jun 07, 2017

News Scan for Jun 07, 2017

NIH director stays
Zika DNA vaccine
Plague in New Mexico
Hepatitis A in tuna

Oct 18, 2012

Oct 18, 2012

HHS seeks comments on risks of H5N1 research

(CIDRAP News) – Federal health officials are inviting the public to weigh in on whether research on H5N1 avian influenza viruses, including strains modified in the lab to make them more transmissible, is risky enough to require new safety regulations and precautions.

Oct 10, 2012

Oct 10, 2012

Changes in select agent rules concern public health labs

(CIDRAP News) – The Centers for Disease Control and Prevention (CDC) has revised its list of potentially dangerous biological agents and toxins and the regulations covering them, and some of the changes have public health laboratories concerned.

Jul 24, 2008

Jul 24, 2008

BioWatch demands on state labs called burdensome

(CIDRAP News) – The president of the Association of Public Health Laboratories (APHL) complained to Congress last week that the federal program that monitors the air for dangerous pathogens in major cities is a heavy burden on state and local laboratories.

Nov 08, 2007

Nov 08, 2007

HHS issues guide for using call centers in emergencies

(CIDRAP News) – The Department of Health and Human Services (HHS) recently released a guide to help communities retool their health-related call centers into systems for meeting the needs of the public in homes or shelters during emergencies such as a pandemic or bioterrorist attack.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»